Site Search

 

 

 

 

 

Home
General Topics
       What is Dialysis?
       Residual Renal Function
          The Importance of RRF
       Diabetes Management
          PD and the Diabetic Patient
          General Facts: Diabetes
       Renal Osteodystrophy
          Renal Osteodystrophy Clinical Studies
       Numbers-Their Use and Interpretation
       Basic Statistics
       Other
          Vaccinating CKD and Dialysis Patients
          32 yr dialysis patient receives Achievement award
Peritoneal Dialysis
       History of PD
          PD - The Foundations
          Early Clinical Experiences with PD
       Basic Principles of PD
          Anatomy of the Peritoneum
          Physiology of the Peritoneum
       Peritoneal Transport 
          Understanding Testing Methods
          Transport Status:Classification and Implications
          Peritoneal Function After Exposure to PD
       Modalities of Therapy
          PD Techniques
          PD Modalities
       PD Adequacy
          Prescribing Dialysis
             Targets of PD Prescription
             Determinants of Dose
             Exchange Volume and Position
             How to Reach the Goals
             Monitoring the PD Patient
             Evaluating the Patient as a Whole
             StdKt/V - Dose Equivalency
       Ultrafiltration
          Importance of Volume Control
          How to Achieve Adequate PD UF
       Clinical Procedures
       Complications
          Non-Infectious Complications of PD
          Peritoneal Dialysis-Related Infections
             Management of ESI
             Diagnosis and Treatment of Peritonitis 
       Dialysis Access
          The Evolution of PD Catheters
          Preop Management
          Placement of PD Catheters
          Intraoperative Management
          Post Operative Care and Management
          Complications of PD Catheters
       Clinical Outcomes
          Clinical outcomes of PD and HD
       Peritoneal Dialysis in Children
          Pediatric ESRD Incidence, Prevalence and Mortality
          Management of the pediatric patient on PD
          Utilization of PD for Acute Renal Failure and ESRD
          Prescription principles, adequacy and PET
          Additional care considerations: Nutrition, Growth,
       PD in the ICU
       Home Program Management
Hemodialysis
       History of Hemodialysis
       Kinetic Principles
          Impact of t & Kr on Kt/V
          StdKt/V - Dose Equivalency
       Modalities of Therapy
          Hemodialysis Regimens/Prescriptions
          Extracorporeal Modalities
       Home HD
          Introduction
          HD Regimens/Prescriptions
          The Influence of Dose, Time & Frequency
          Every other day HD (HD3.5)
          Time Versus Dialysis-Free Interval
          Benefits of Increased HD Frequency
          Increased Frequency – Other Modalities
          Potential Lifestyle Benefits of HD3.5
          Home Program Management
             Establishing a Home Program
       Intradialytic Complications
       Adequacy
          Difficulties in Prescribing Adequate Dialysis
       Sodium Modeling
       Hemodialysis Access
          Introduction to Vascular Access
          Overview of Arteriovenous Fistula
          Overview of Arteriovenous Grafts
          Overview of Central Venous Catheters
          Vascular Access Monitoring and Surveillance
       Access Complications
          Overview of Hemodialysis Complications
          AVF Stenosis
          Interventions for AVF and AVG Stenosis
          Primary Fistula Failure
          Catheter Related Bacteremia
Sorbent Technology
       History of Sorbent Technology
Seminars & Education
Educational Initiatives
Training Resources
       Kidney Options Kidney Options
       Patient Training Resources
       Training Resources for Professionals Training Resources for Professionals
Product Information
       Peritoneal Dialysis
          Fresenius Peritoneal Dialysis Connections
          WebEx Teleconference Workshops
       Hemodialysis
       Home Hemodialysis
Glossary
Links
       Journals
       Organizations
       Other Links
Contact Information
Calendar of Events
Contributors

Volume and Blood Pressure Control

All studies that have specifically addressed issues of volume and hypertension management report improvement.  A good example is that where Fagugli et al. reported the results of a cross-over in 12 stable maintenance dialysis patients1. Volume was assessed by bioimpedance, blood pressure by 24-hour ambulatory measurements and cardiac dimensions by echocardiography.  

 

 

10 Fall in ECV sm.gif

Click image to enlarge

 

 

10 Circadian BP sm.gif

Click image to enlarge

 

 

 

10 LVMI sm.gif

 

 

Extracellular volume as percent body weight (top); 24-hour daytime and nighttime systolic BP (middle) and LV dimensions (bottom) in patients converted from conventional to short daily HD

Click image to enlarge

 

Conventional HD comprised thrice-weekly sessions of approximately 4 hours; for sDHD, the same total weekly dialysis time was divided equally over 6 dialysis sessions.  Each regimen was maintained for 6 months.  Extracellular water expressed as percentage body weight decreased from 53% to 48% (p<0.02).  Systolic and diastolic BP fell significantly (p<0.01).  Fall in 24 hour SBP correlated with the decrease in ECV (r=0.63 p<0.01).  Seven of 8 patients discontinued use of antihypertensive medications. The LV mass index decreased from 149 g/m2 to 120 g/m2 (p<0.01) and also correlated with reduction in ECV (r=0.66 p< 0.01).  A trend for lower LV internal diameter was observed.

 

Chan et al. reported the effects on BP and LV mass in 28 patients treated by long nocturnal dialysis (lNHD) for a mean of 3.4 years compared to 13 patients using conventional HD at home for 2.8 years2.

 

 

10 BP in CHD and lNHD sm.gif

 

Click image to enlarge

 

 

10 LVMI in CHD and lNHD sm.gif

 

BP (left) and left ventricular mass (right) responses to long nocturnal (lNHD) and conventional HD (CHD).

Click image to enlarge

 

Blood pressure fell significantly in patients treated with lNHD despite a reduction in antihypertensive agents (score 1.8 to 0.3).  No change in BP or antihypertensives was found for CHD.  Whereas LV mass index tended to rise in patients treated by CHD, there was a significant fall (p<0.05) in the patients treated with lNHD. Interestingly, no change in ECF volume was seen in the patients treated with lNHD.

 

From these data it appears that the two approaches to increased frequency – short daily and long nocturnal – are effective in improving BP management and reversing LV hypertrophy.  In the London daily/nocturnal HD study it was possible to compare the effect of both treatment schedules within a single centre3.  This study was a case controlled study comparing short daily (n=11) and long nocturnal (n=12) for a period of 18 months follow-up.  Each case selected for increased frequency had a matched control treated by conventional HD.  Both regimens of increased frequency HD were associated with significant lowering of mean arterial pressure (MAP) despite reduction in use of antihypertensives.  No change in MAP for matched controls was found and the use of antihypertensives increased slightly.  Volume and LV dimensions were not reported.

 

Why does blood pressure prove more manageable when dialysis frequency is increased (or when Tassin-style dialysis is performed)? The data from Fagugli1 suggest that reduction in volume overload is a factor whereas no change in ECF volume was detected by Chan2.  In other publications, Chan and the Toronto group have identified a reduction in total peripheral vascular resistance and increased endothelium-dependent vasodilatation in response to treatment by long nocturnal dialysis.  Identifying the mechanisms – volume related, hemodynamic related and/or some complex effect related to changed vasoreactive substances – will be important in determining the optimum increased frequency regime.

 

Back to Reported Benefits of Increased Diaysis Frequency          Next

 

References:

 

  1. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U.  Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38:371-376, 2001
  2. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61:2235-2239, 2002
  3. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 42 (Suppl 1):s13-s17, 2003
Print  
© 2006-2012, Fresenius Medical Care North America. All Rights Reserved. | Terms of Use | Privacy Statement | Register | Login